Medscape: AF detection by smartwatch challenging in some patients
UC expert says patients at risk for developing AF could benefit from monitoring using a smartwatch
New research shows that the ability of the Apple Watch to detect atrial fibrillation (AF) is significantly affected by underlying ECG abnormalities such as sinus node dysfunction, atrioventricular block, or intraventricular conduction delay. In a story on the research published by Medscape, Richard Becker, MD, professor and director, UC Heart, Lung and Vascular Institute and UC Division of Cardiovascular Health and Disease at the UC College of Medicine provided reaction to the research.
Richard Becker, MD/Photo/Andrew Higley/UC Marketing + Brand
"This is exactly the kind of investigation required to improve upon existing detection algorithms that will someday facilitate routine use in patient care," said Becker. "An ability to detect AF in a large proportion of those with the heart rhythm abnormality is encouraging."
The findings should not detract from well-conducted studies in otherwise healthy individuals of varied age in whom AF was accurately detected, he added. "Similarly, an automatic diagnosis algorithm for AF, pending optimization and validation in a large and diverse cohort, should be viewed as a communication tool between patients and healthcare providers."
Patients at risk for developing AF could benefit from continuous monitoring using a smartwatch, said Becker.
"Pre-existing heart rhythm abnormalities must be taken into consideration. Optimal utilization of emerging technology to include wearables requires an understanding of performance and limitations. It is best undertaken in coordination with a healthcare provider."
Lead photo/Onur Binay/Unsplash
Next Lives Here
The University of Cincinnati is classified as a Research 1 institution by the Carnegie Commission and is ranked in the National Science Foundation's Top-35 public research universities. UC's graduate students and faculty investigate problems and innovate solutions with real-world impact. Next Lives Here.
Related Stories
6 ways starting a GLP-1 medication could affect your emotions
May 20, 2026
When patients first start taking a glucagon-like peptide-1 (GLP-1) medication, they probably expect to feel full. But they might not anticipate how it can influence their emotions. The medications act on the stomach and the brain, said Malti Vij, MD, a University of Cincinnati adjunct associate professor in the College of Medicine's Department of Internal Medicine and a diplomate of the American Board of Obesity Medicine.
UC researchers recruit older adults for extreme heat health study
May 20, 2026
The University of Cincinnati’s Center for Collaboration on Climate & Community for Health (C4H) is recruiting older adults to participate in a study tracking their health during periods of extreme summer heat.
$15 million bequest supports endowed chair at UC College of Medicine
May 19, 2026
As a student and resident at the University of Cincinnati College of Medicine, George G. Bemis, Jr., MD, Med ’64, saw firsthand that medicine was more than a profession for those teaching and leading him. Inspired by their sense of calling, he knew he wanted to pursue the same path.